We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.
Medtech Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
MedDay receives €8mm Series A investment from InnoBio and Sofinnova
30 Apr 2013
Executive Summary
InnoBio (managed by CDC Entreprises) and Sofinnova Capital VII have participated in an €8mm ($10.5mm) Series A round for MedDay Pharmaceuticals, a 2011 start-up that is being incubated at Paris’ l’Institut du Cerveau et de la Moelle Epiniere (the Brain and Spinal Cord Institute). Chahra Louafi from CDC and Rafaele Tordjman from Sofinnova were the representatives from each investor.
Deal Industry
Biotechnology
Pharmaceuticals
Deal Status
Final
Deal Type
Financing
Venture Financing
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?